Jennifer Rippon, DO
Pulmonary Disease · Baton Rouge, LANPI 1003020348
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,520 of the $6,773 with a category attached, or 81.5%. 20 manufacturers reported payments, led by Cook Incorporated at 54.9% of the total. 2025 is the largest year on record at $6,435, more than ten times the $42 reported in 2019.
Across 40 payments — averaging $169.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$4K
- Coaptech, Inc.$2K
- Cook Medical LLC$531
- Electromed, Inc.$65
- Abiomed$49
- CSL Behring$47
- plus $331 from 14 others
What the payments were for
- Speaking & faculty fees$5,52082%
- Travel & lodging$3195%
- Food & beverage$93414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 1 | $3,720 |
| Coaptech, Inc. | 4 | $2,030 |
| Cook Medical LLC | 2 | $531 |
| Electromed, Inc. | 9 | $65 |
| Abiomed | 1 | $49 |
| CSL Behring | 2 | $47 |
| Johnson & Johnson | 2 | $40 |
| Grifols USA, LLC | 1 | $37 |
| Viatris Specialty LLC | 1 | $34 |
| Ambu Inc. | 7 | $29 |
| United Therapeutics Corporation | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Shionogi Inc | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| GSK | 1 | $19 |
| Inogen, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PUMA SYSTEM$1,964
- Blue Rhino$531
How this compares
$6,773 in reported general payments places this provider in the 60th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Baton Rouge
- Hollis O NealBaton Rouge$418K
- Robert HinkleBaton Rouge$19K
- Tarek AbdallahBaton Rouge$12K
- Alexander MulamulaBaton Rouge$12K
- Brad VincentBaton Rouge$12K
- Andrea EspinozaHouma$655K
- Joseph LaskyNew Orleans$447K
- Ramsy AbdelghaniNew Orleans$308K
- Juzar AliNew Orleans$216K
- Warren BotnickNatchitoches$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.